crystepin T
90155-20-7
|
3-[(E)-[5-hydroxy-4-(3-hydroxynon-1-ynyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]methyl]benzoic acid
96744-62-6
|
Bu2Sn[CH(OH)Ph]2
871704-87-9
|
W(CH-t-Bu)(N-2,6-diisopropylphenyl)(hexafluoro-tert-butoxide)2
101249-40-5
|
(3Z)-3-[[4-[(3-methylpyridin-2-yl)sulfamoyl]phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid
42753-53-7
|
Ge(CH{(CH3)CN-2,6-iPr2C6H3}2)Cl
334719-93-6
|
K(CH(PPh2NSiMe3)2-κ(2)N,N',κC)
373387-05-4
|
Ta(CH-t-Bu)(DIPP)3(THF)
114530-92-6
|
HX-CH 44BS
95893-19-9
|
4-Amino-N-(tetrahydro-2H-pyran-4-yl)-2-(trifluoromethyl)benzamide
2808121-88-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
Paritaprevir metabolite M24
2205844-41-1
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
